Ashton Thomas Private Wealth’s TherapeuticsMD TXMD Stock Holding History

Ashton Thomas Private Wealth’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$33.7K	Buy	+16,581	New	+$34.7K	﹤0.01%	1469

Other funds holding TXMD

Tejara Capital London, United Kingdom $205M AUM 0.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Provenance Wealth Advisors Fort Lauderdale, Florida $1.69B AUM 11.53% 1-Year Est. Return

Ashton Thomas Private Wealth's TXMD Position: Q3 2026 in Review

Ashton Thomas Private Wealth opened a new position in TherapeuticsMD (TXMD) in Q3 2026: 16,581 shares worth $33.7K. The stake represents ﹤0.01% of the portfolio and ranks #1469 among its holdings.

15 funds tracked by Wall St. Rank hold TXMD as of Q3 2026.

Ashton Thomas Private Wealth held 16,581 shares of TherapeuticsMD worth $33.7K as of Q3 2026.
TherapeuticsMD was a new Ashton Thomas Private Wealth position in Q3 2026.
TherapeuticsMD made up ﹤0.01% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #1469 holding.
15 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.